The Omicron variant, for example, is more infectious than the Delta variant and may cause breakthrough infections in people who are vaccinated. However, variants may still cause illness in some people who are vaccinated. The available COVID-19 vaccines are effective against most variants of the virus, including the Delta variant. Globally, other vaccines are available or are in process of receiving Emergency Use Listing by the World Health Organization (WHO). In the United States, the 3 vaccines in use are made by Pfizer-BioNTech (Comirnaty), Moderna (Spikevax), and Janssen, manufactured by Johnson & Johnson. There are several COVID-19 vaccines that are now in use in different parts of the world. Patients should talk with their oncologists and health care teams to discuss their options to protect themselves from infection. The American Society of Clinical Oncology (ASCO) is aware that people with cancer and cancer survivors, particularly those with compromised immune systems, are likely worried about the potential impact of COVID-19 on their health. Markham is the Cancer.Net Associate Editor for Gynecologic Cancers and the past chair of ASCO's Cancer Communications Committee.
She specializes in the treatment of gynecologic cancers. Merry Jennifer Markham, MD, FACP, FASCO, is Chief of the University of Florida (UF) Division of Hematology & Oncology, a Clinical Professor in the UF College of Medicine, and the Associate Director for Medical Affairs at the UF Health Cancer Center. It received the award of Distinction from the eHealthcare Awards in the Best COVID-19 Pandemic Related Communications category.
This post is reviewed twice a week and updated as needed.
0 kommentar(er)
